biopharma

PRINCETON, New Jersey, April 30, 2026 Made Scientific, a U.S.-based cell therapy contract development and manufacturing organization (CDMO), announced...

MUMBAI, India and TOKYO, Japan, April 16, 2026 Piramal Pharma Solutions (PPS) and Ajinomoto Bio-Pharma Services have announced a...

FOSTER CITY, Calif., April 17, 2026 Gilead Sciences, Inc. has announced that it has obtained all required regulatory approvals...

SOUTH SAN FRANCISCO, Calif., April 16, 2026 Aligos Therapeutics has entered into an exclusive licensing agreement with Xiamen Amoytop...

Houston, Texas, U.S. | April 15, 2026 Eli Lilly and Company has announced a strategic agreement to acquire CrossBridge...

HOUSTON, Texas | April 10, 2026 FibroBiologics has unveiled promising preclinical data for its novel thymus organoid platform, demonstrating...

WALTHAM, Massachusetts | April 9, 2026 Swedish Orphan Biovitrum (Sobi) has announced that Health Canada has approved EMPAVELI® (pegcetacoplan),...

CRANFORD, N.J., March 31, 2026 Citius Oncology, Inc. has reported strong early momentum following the U.S. launch of its...

LEIDEN, Netherlands, March 27, 2026 Pharming Group N.V. announced that the Committee for Medicinal Products for Human Use (CHMP)...

SANTA CRUZ, Calif., March 16, 2026 Unnatural Products has announced the successful closing of a $45 million Series B...